This page shows the latest salmeterol news and features for those working in and with pharma, biotech and healthcare.
dose Sal/Flu (salmeterol xinafoate/fluticasone propionate).
GSK’s respiratory business has been hit with the loss of patent protection for its COPD blockbuster Seretide/Advair (fluticasone propionate/salmeterol) – Trelegy is GSK’s answer to the increased competition
She said it was encouraging that in the year that generic competition really bit hard into sales of GSK’s longstanding respiratory blockbuster Advair/Seretide (fluticasone propionate/salmeterol), the group was
Meanwhile, the COPD category has been affected by the arrival of generics of big-selling brands like GlaxoSmithKline’s Advair (salmeterol/fluticasone propionate).
Teva won approval for its AirDuo product last year in the US, providing the same active ingredients as Advair but with a lower dose of salmeterol which means it is not
Much of its recent success was built on the back of combination therapies that were first introduced in the late 1980s, and culminated in its blockbuster Advair/Seretide (salmeterol/fluticasone propionate)
More from news
Approximately 1 fully matching, plus 89 partially matching documents found.
Our goal is to identify and embed transformational patient insights as a fundamental part of the drug development process. As...